Harbor Investment Advisory, LLC Bausch Health Companies Inc. Transaction History

Harbor Investment Advisory, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$7.06 - $23.63 $1,059 - $3,544	-150 Reduced 64.1%	84 $1,000
Q1 2022 Apr 20, 2022	BUY	$21.6 - $27.79 $108 - $138	5 Added 2.18%	234 $5,000
Q4 2021 Jan 10, 2022	BUY	$23.0 - $29.01 $1,817 - $2,291	79 Added 52.67%	229 $6,000
Q3 2021 Oct 12, 2021	BUY	$25.04 - $30.06 $3,756 - $4,509	150 New	150 $4,000
Q1 2021 Apr 16, 2021	SELL	$21.37 - $34.38 $25,644 - $41,256	-1,200 Closed	0 $0

Q4 2020 Feb 04, 2021	SELL	$15.31 - $21.12 $3,062 - $4,224	-200 Reduced 14.29%	1,200 $25,000
Q1 2020 May 11, 2020	BUY	$12.98 - $30.25 $2,596 - $6,050	200 Added 16.67%	1,400 $22,000
Q4 2019 Jan 16, 2020	BUY	$18.89 - $31.89 $22,668 - $38,268	1,200 New	1,200 $36,000

270

198M

2.54M

6.44M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.27B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbor Investment Advisory, LLC with notifications on news.